Based in Sweden, Aplagon is a startup founded in 2018. Brouky records 3 investors associated with the company.
Aplagon is a clinical stage biopharmaceutical company developing first-in-class therapeutics for thromboinflammatory diseases, including thrombotic and vascular occlusion related cardiovascular diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.